Synopsys, Inc.

(NASDAQ Global Select)
Bullish +75

Synopsys Price Prediction: The AI Play With Big Upside This Year

πŸ“ˆ Synopsys stock has rallied 21.78% in the past month following a recent Q3 selloff.

🎯 Our price target for Synopsys is $608.97, suggesting 19.4% upside from the current trading price of $510.02.

πŸ’Ό We maintain a buy rating with 90% confidence based on strong forward earnings visibility and debt reduction.

πŸ“‰ The stock fell to as low as $389.83 in November 2025 after a poor Q3 FY25 result before recovering significantly.

πŸ€– Q1 FY26 revenue surged 65.4% year-over-year to $2.41 billion, with non-GAAP EPS beating consensus by 5.98%.

πŸ’Έ Operating cash flow swung from negative $67 million to positive $856.83 million in the first quarter.

πŸ›οΈ Management paid down $3.45 billion in long-term debt during Q1, significantly improving the balance sheet.

πŸ”­ FY26 guidance projects revenue between $9.56 and $9.66 billion, including approximately $2.9 billion from Ansys.

🧠 CEO Sassine Ghazi highlighted a compelling historical roadmap as AI-driven demand strengthens chip design R&D.

πŸ“Š The Ansys acquisition expanded the company's addressable market by 63% to a total of $31 billion.

πŸ‚ Wells Fargo raised its price target to $505 on May 14, citing potential for a 33.79% total return in bull scenarios.

⚠️ High valuation is a concern with a trailing P/E of 78 and forward P/E of 36 ahead of next earnings.

πŸ‡¨πŸ‡³ China represents roughly 10% of revenue and remains vulnerable to ongoing U.S. export control restrictions.

🐻 Bears point to GAAP net income falling 78.03% year-over-year due to significant non-cash amortization costs.

πŸ”„ Morgan Stanley flagged potential growth deceleration while Piper Sandler maintains a Neutral rating with a $430 target.

πŸ’° The bull thesis relies on executing the Ansys integration and maintaining strong demand for AI-led Electronic Design Automation (EDA).

⚑ Strong cash flow of $2.2 billion in FY26 plus a $2 billion share repurchase program supports our high conviction buy.

πŸ“… Positive sentiment depends on Q2 results staying within the $2.225 to $2.275 billion revenue guidance range.

πŸ”΄ Risks include potential tightening of export restrictions to China or failure of Design IP margins to recover.

πŸš€ Significant upside or downside remains possible based on China policy shifts and accelerated cost synergy execution.

Bullish Signals
  • Synopsys staged a dramatic comeback, climbing 21.78% in the past month after a downturn through late 2025.
  • Q1 FY26 revenue surged 65.4% year-over-year to $2.41 billion, significantly beating analyst consensus estimates.
  • Non-GAAP EPS of $3.77 exceeded expectations, with operating cash flow swinging to positive $856.83 million from negative $67 million the prior year.
  • Management successfully paid down $3.45 billion in long-term debt during the quarter, strengthening the balance sheet.
  • The Ansys integration is proving successful, contributing roughly $2.9 billion in revenue and expanding the addressable market by 63% to $31 billion.
  • Analyst Wells Fargo raised its price target to $505 on May 14, reflecting growing confidence in the company's growth potential.
  • Forward operating cash flow is expected to reach $2.2 billion for FY26, with a plan to replenish capital through $2 billion of share repurchases.
  • CEO Sassine Ghazi highlighted a compelling historical roadmap driven by AI-fueled chip design R&D and strong forward EPS visibility.
Risk Factors
  • Synopsys stock collapsed to $389.83 in November 2025 following a brutal Q3 FY25 miss, indicating recent significant volatility and investor panic.
  • GAAP net income plummeted 78.03% year-over-year in Q1, although analysts note this is obscured by non-cash charges like $404 million in acquired intangible amortization.
  • China accounts for approximately 10% of revenue and remains highly exposed to U.S. export controls, creating a specific geopolitical downside risk.
  • Morgan Stanley has flagged potential growth deceleration, and Piper Sandler holds a Neutral rating with a $430 target price, suggesting analyst skepticism.
  • The bull case relies heavily on successful Ansys integration and continued AI-driven demand; if design IP margins fail to recover, the thesis weakens significantly.
  • Operating margins contracted 200 basis points due to aggressive AI infrastructure spending, which could impact long-term profitability.
  • Significant upside or downside could result from China export policy shifts, introducing a binary regulatory risk that is not priced in.
Full Analysis
Synopsys (NASDAQ: SNPS) has staged a dramatic recovery, climbing 21.78% in the past month after a decline to $389.83 by November 2025 following a Q3 FY25 miss. The stock currently trades at $510.02 and has rallied year-to-date by 8.58%, with a 52-week range between $376.18 and $651.73. This resurgence is attributed to strong integration of Ansys and sustained demand for AI-driven chip design tools. First quarter results for fiscal year 2026, reported on February 25, showed significant growth with revenue reaching $2.41 billion, a 65.4% year-over-year increase, and non-GAAP earnings per share of $3.77, beating the consensus of $3.55 by 5.98%. Operating cash flow swung from negative $67 million a year earlier to $856.83 million, while management utilized this liquidity to pay down $3.45 billion in long-term debt during the quarter. GAAP net income declined 78.03% year over year due to non-cash charges including $404 million in acquired intangible amortization and $118 million in restructuring costs. The bullish thesis for Synopsys relies on forward guidance projecting FY26 revenue between $9.56 billion and $9.66 billion, with non-GAAP EPS expected to range from $14.38 to $14.46. This forecast includes approximately $2.9 billion in Ansys revenue following a merger that expanded the addressable market by 63% to $31 billion. CEO Sassine Ghazi emphasized the company has the most compelling roadmap in its history driven by AI fueling chip design R&D. Wells Fargo raised its price target to $505 on May 14, and analysts cite strong cash flow visibility with expected FY26 operating cash flow of $2.2 billion plus potential share repurchases. Conversely, bearish concerns center on a trailing P/E ratio of 78 compared to a forward P/E of 36, as well as exposure to U.S. export controls affecting revenue from China which accounts for roughly 10%. Morgan Stanley has flagged growth deceleration while Piper Sandler maintains a Neutral rating with a $430 target. The bull scenario price target reaches $682.36 (a 33.79% total return), whereas the bear case lands at $527.85. Future performance will likely hinge on Q2 revenue meeting the $2.225 to $2.275 billion guide and whether margin expansion through cost synergies materializes as expected.